[go: up one dir, main page]

BRPI0513903A - derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos - Google Patents

derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos

Info

Publication number
BRPI0513903A
BRPI0513903A BRPI0513903-1A BRPI0513903A BRPI0513903A BR PI0513903 A BRPI0513903 A BR PI0513903A BR PI0513903 A BRPI0513903 A BR PI0513903A BR PI0513903 A BRPI0513903 A BR PI0513903A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
ketolide derivatives
same
preparation processes
antimicrobial agents
Prior art date
Application number
BRPI0513903-1A
Other languages
English (en)
Inventor
Biswajit Das
Mohammad Salman
Atul Kashinath Hajare
Ramadass Venkataramanan
Rita Katoch
Rajesh Kumar
Gobind Singh Kapkoti
Anjan Chakrabarti
Anish Bandyopadhyay
Santosh Haribhau Kurhade
Yogesh Baban Surase
Ashok Rattan
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of BRPI0513903A publication Critical patent/BRPI0513903A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

DERIVADOS DE CETOLìDEOS úTEIS COMO AGENTES ANTIMICROBIANOS, SEUS PROCESSOS DE PREPARAçãO E COMPOSIçõES FARMACêUTICAS COMPREENDENDO OS MESMOS. A presente invenção refere-se a derivados de cetolídeos, os quais podem ser usados como agentes bacterianos. Particularmente, os compostos aqui descritos podem ser usados no tratamento ou na prevenção de condições causadas ou influenciadas por bactérias Gram-positivas, Gram-negativas ou anaeróbicas, mais particularmente contra, por exemplo, Staphylococci, Streptococci, Enterococci, Haemophilus, Moraxalla spp., Chlamydia spp., Mycoplasm, Legionella spp., Mycobacterium, Helicobacter, Clostridium, Bacteroides, Corynebacterium, Bacillus ou Enterobactericeae. A presente invenção refere-se ainda a processos preparação dos referidos derivados de cetolídeos, composições farmacêuticas dos mesmos e a métodos tratamento de infecções bacterianas.
BRPI0513903-1A 2004-07-28 2005-07-28 derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos BRPI0513903A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1400DE2004 2004-07-28
IN1388DE2005 2005-05-30
PCT/US2005/027875 WO2006080954A1 (en) 2004-07-28 2005-07-28 Ketolide derivatives as antibacterial agents

Publications (1)

Publication Number Publication Date
BRPI0513903A true BRPI0513903A (pt) 2008-05-20

Family

ID=36480874

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513903-1A BRPI0513903A (pt) 2004-07-28 2005-07-28 derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos

Country Status (6)

Country Link
US (1) US20080287376A1 (pt)
EP (1) EP1794171A2 (pt)
JP (1) JP2008508322A (pt)
BR (1) BRPI0513903A (pt)
RU (1) RU2397987C2 (pt)
WO (1) WO2006080954A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3738591A3 (en) 2003-03-10 2021-03-24 Merck Sharp & Dohme Corp. Novel antibacterial agents
WO2006067589A1 (en) 2004-12-21 2006-06-29 Pfizer Products Inc. Macrolides
EP1954294A2 (en) 2005-11-23 2008-08-13 Ranbaxy Laboratories Limited Use of macrolide derivatives for treating acne
WO2007060618A2 (en) * 2005-11-23 2007-05-31 Ranbaxy Laboratories Limited Macrolides derivatives as antibacterial agents
US8273720B2 (en) * 2007-09-17 2012-09-25 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl macrolide derivatives
MX2010002932A (es) * 2007-09-17 2010-05-27 Enanta Pharm Inc Macrolidos de biarilo con puente en 6, 11.
WO2009055557A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
HRP20160222T1 (hr) * 2008-10-24 2016-04-08 Cempra Pharmaceuticals, Inc. Biozaštite uporabom makrolida koji sadrže triazol
WO2010096051A1 (en) * 2009-02-18 2010-08-26 Enanta Pharmaceuticals, Inc. 6,11-bicyclolides: bridged biaryl amide macrolide derivatives
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
AU2010292010B2 (en) 2009-09-10 2016-01-07 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
NZ602544A (en) 2010-03-22 2014-11-28 Cempra Pharmaceuticals Inc Crystalline forms of a macrolide, and uses therefor
RU2608390C2 (ru) 2010-05-20 2017-01-18 Семпра Фармасьютикалз, Инк. Способы получения макролидов и кетолидов, и промежуточных соединений для их получения
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
PL2673285T3 (pl) * 2010-12-09 2017-12-29 Wockhardt Limited Związki ketolidowe
HK1205939A1 (en) 2012-03-27 2015-12-31 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
CA3130061C (en) 2013-04-04 2024-05-28 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
CN105524132B (zh) * 2014-09-30 2019-07-02 中国医学科学院药物研究所 含有喹啉取代基的红霉素a酮内酯类抗生素衍生物、其制备方法及应用
US10633407B2 (en) 2014-10-08 2020-04-28 President And Fellows Of Harvard College 14-membered ketolides and methods of their preparation and use
JP2018509452A (ja) 2015-03-25 2018-04-05 プレジデント アンド フェローズ オブ ハーバード カレッジ 修飾デソサミン糖をもつマクロライドおよびその使用
CN106518939B (zh) * 2015-09-14 2019-12-31 江苏奥赛康药业有限公司 一种制备Solithromycin化合物的方法
CN107129514B (zh) * 2016-03-02 2019-12-13 中国医学科学院药物研究所 红霉素a酮内酯类抗生素衍生物、其制备方法及应用

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3681325A (en) * 1970-09-30 1972-08-01 Abbott Lab De(n-methyl)-n-substituted derivatives of erythromycin
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CA2263972C (en) * 1996-09-04 2008-01-29 Abbott Laboratories 6-o-substituted ketolides having antibacterial activity
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
IL134608A0 (en) * 1997-09-30 2001-04-30 Abbott Lab 3'-n- modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2785612A1 (fr) * 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
BR9914998A (pt) * 1998-11-03 2001-07-10 Pfizer Prod Inc Antibióticos macrólidos
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
CZ20012675A3 (cs) * 1999-01-27 2002-04-17 Pfizer Products Inc. Ketolidová antibiotika
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
RU2001130900A (ru) * 1999-04-16 2003-08-27 Орто-Макнейл Фармасьютикал, Инк. (Us) Кетолидные антибактериальные средства
US6590083B1 (en) * 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
MXPA01010521A (es) * 1999-04-16 2003-08-19 Johnson & Johnson Antibacteriales de cetolidos.
JP2001181294A (ja) * 1999-12-27 2001-07-03 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
JP2002173498A (ja) * 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
US6472372B1 (en) * 2000-12-06 2002-10-29 Ortho-Mcneil Pharmaceuticals, Inc. 6-O-Carbamoyl ketolide antibacterials
JP2003073394A (ja) * 2001-09-04 2003-03-12 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
WO2004096822A2 (en) * 2003-04-25 2004-11-11 Chiron Corporation Pyridyl substituted ketolide antibiotics
US7271155B2 (en) * 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives

Also Published As

Publication number Publication date
RU2007107340A (ru) 2008-09-10
US20080287376A1 (en) 2008-11-20
WO2006080954A1 (en) 2006-08-03
EP1794171A2 (en) 2007-06-13
RU2397987C2 (ru) 2010-08-27
JP2008508322A (ja) 2008-03-21

Similar Documents

Publication Publication Date Title
BRPI0513903A (pt) derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos
Yu et al. Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus
Galm et al. Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis
BRPI0417800A (pt) derivados de oxazolidinona, método de preparo dos mesmos e composição farmacêutica
Dong et al. Effects of sub-minimum inhibitory concentrations of ciprofloxacin on biofilm formation and virulence factors of Escherichia coli
NZ591051A (en) C7-fluoro substituted tetracycline compounds
Woo et al. Facilitation of horizontal transfer of antimicrobial resistance by transformation of antibiotic-induced cell-wall-deficient bacteria
WO2009073545A3 (en) Tetrahydro-isoquinoline ppat inhibitors as antibacterial agents
Lion et al. Antimicrobial susceptibilities of Pasteurella strains isolated from humans
Yamashita et al. Antibacterial activity of disodium succinoyl glycyrrhetinate, a derivative of glycyrrhetinic acid against Streptococcus mutans
WO2007060518A3 (en) Ketolide derivatives as antibacterial agents
NO20073490L (no) Antibiotikum 107891, dets faktorer A1 og A2, samt farmasoytisk akseptable salter og sammensetninger, og anvendelser derav
Rahim et al. Pseudomonas aeruginosa as a Powerful Biofilm Producer and Positive Action of Amikacin Against Isolates From ChronicWounds
Champney et al. Linezolid is a specific inhibitor of 50S ribosomal subunit formation in Staphylococcus aureus cells
MXPA06000691A (es) Antibiotico 107891, sus factores a1 y a2, sales y composiciones farmaceuticamente aceptables y uso de las mismas.
WO2006046112A3 (en) Ketolide derivatives as antibacterial agents
ATE414082T1 (de) Antibiotische tetrahydro-b-carbolinderivative
WO2009073534A3 (en) Bicyclic ppat inhibitors as antibacterial agents
WO2009102377A3 (en) Antibiotic tetrahydro-beta-carboline derivatives
WO2008111020A3 (en) Macrolide derivatives as antibacterial agents
WO2007060618A3 (en) Macrolides derivatives as antibacterial agents
Giacobbe et al. Effect of susceptibility testing conditions on the in vitro antibacterial activity of ETX0914
WO2004060272A3 (en) Delivery of peroxide-generating enzymes to the vaginal tract
Mardani et al. Zinc oxide nanoparticles: A promising solution for controlling the growth of gentamicin-resistant uropathogenic Escherichia coli
WO2005037272A8 (en) Benzimidazole derivatives and use thereof as peptide deformylase inhibitors

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.